210755-75-2

Downstream Products

• 210755-79-6 (2S,3S,4S,5R,6S)-3-((2R,3S,4R,5R,6R)-6-Benzyloxymethyl-3,4,5-trimethoxy-tetrahydro-pyran-2-ylmethyl)-4,5,6-trimethoxy-tetrahydro-pyran-2-carboxylic acid benzyl ester 
• 192505-51-4 [(2S,3R,4S,5R,6S)-3-((2R,3S,4R,5R,6R)-6-Benzyloxymethyl-3,4,5-trimethoxy-tetrahydro-pyran-2-ylmethyl)-4,5,6-trimethoxy-tetrahydro-pyran-2-ylmethoxy]-tert-butyl-dimethyl-silane 
• 210755-77-4 (2R,3R,4R,5S,6R)-2-Benzyloxymethyl-6-[(2S,3R,4S,5R,6S)-2-(tert-butyl-dimethyl-silanyloxymethyl)-4,5,6-trimethoxy-tetrahydro-pyran-3-ylmethyl]-4-methoxy-tetrahydro-pyran-3,5-diol 
• 210755-76-3 methyl 4-C-(6-O-benzyl-3-O-methyl-α-D-glucopyranosylmethyl)-4-deoxy-2,3-di-O-methyl-α-D-glucopyranoside 

Relevant academic research and scientific papers

Synthesis of a C-disaccharide glycosyl donor as a key building block for the preparation of new biologically active heparin pentasaccharide mimetics

The synthesis of the C-disaccharide imidate 34, a key synthon for the synthesis of heparin pentasaccharide mimetics, is described.The C-interglycosidic bond was established through 9-endo-trig radical cyclization from two tethered monosaccharides.It was followed by conversion of the reducing end glucose unit into the required glucuronic acid derivative. - Keywords: heparin; silicon tether; radical cyclization; C-disaccharide; carbohydrate mimetics